Background
Welcome to the press page of leserlich.info. We are happy to help with your press coverage.
leserlich.info digital press pack
Press release on the relaunch of the »leserlich.info« website dated 28.11.2024, Format: .docx, Size: 18KB (in German)
Image material for the relaunch of the website »leserlich.info« from 28.11.2024, format: .zip, size: 650KB
The download contains image material in web-optimized resolution for online editorial use. The photo credit for all press photos is »DBSV/adlerschmidt«. For high-resolution images for print use, please contact our press contact person.
Press contact
Volker Lenk
Press officer for the German Federation of the Blind and Partially Sighted (Deutscher Blinden- und Sehbehindertenverband, DBSV)
Phone: +49 30 28 53 87-140
Fax: +49 30 28 53 87-200
v.lenk@dbsv.org
Further press releases
Press release on the launch of the internet platform leserlich.info from April 19, 2017 (in German)
Press release on the launch of the pilot applications for inclusive communication design from March 1, 2017 (in German)
Download press photo: Cover page of the DBSV magazine “Sichtweisen”, March 2017 issue - Image credit: DBSV (in German)
You will find an article providing more detailed information starting on p. 20 of the PDF document below. To quote sizeable passages or publish an article in full, please contact v.lenk@dbsv.org to request the text as a Word document and to agree on a source reference.
DBSV magazine “Sichtweisen”, March 2017 issue, view PDF for browsing Format: pdf Size: 1.7 MB (in German)
The document is a read-only PDF file. It shows the graphic design of the Sichtweisen pilot project and is not fully accessible. We also provide a description of the graphic design for blind visitors to the site in Word format.
DBSV magazine “Sichtweisen”, March 2017 issue - Description of the design Format: docx Size: 15.5 KB (in German)
The Inclusive Design project ran until the end of June 2017 and was funded by Aktion Mensch. Other supporters included adlerschmidt, MSD, Santhera (Germany) and blista. Initial project development work was carried out with support from Novartis.